• Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

  • Jul 26 2024
  • Length: 39 mins
  • Podcast

Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma By cover art

Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

Listen for free

View show details

  • Summary

  • touchPANEL DISCUSSION for touchONCOLOGY

    Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.

    The experts

    • Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
    • Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
    • Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.

    This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.

    For further information visit: https://touchoncologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma

    Show more Show less
activate_primeday_promo_in_buybox_DT
Science
Show more Show less

What listeners say about Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available